Table of Contents Table of Contents
Previous Page  211 / 398 Next Page
Information
Show Menu
Previous Page 211 / 398 Next Page
Page Background

206

The use of fluorescent lecthins to detect oral cancer and

dysplasia

J. Kademani

∗

, J. Baeten, A. Johnson, S. Claiborne, M. Idle,

K. Patel, M. Kuriakose, D. Kademani

North Memorial Medical Center, MN, United States

Oral cancer is the sixth most common cancer in the world with

approximately 275,000 people diagnosed each year. Early stage

diagnosis is critical to improve survival. Our study tested a new

oral screening technique based on lecithin histochemistry. The

use of fluorescent lecthins as an adjunct to clinical examination

was more sensitive and accurate than traditional screening meth-

ods, resulting in increased and earlier detection of oral cancer and

dysplasia.

The inclusion criteria were subjects with the following char-

acteristics: (i) absence of risk-habits (tobacco and alcohol usage,

>40 years old or (ii) presence of a clinically suspicious oral lesion

(potentially benign, premalignant, or malignant). The test utilised

fluorescent molecular probes (Dye 1, a nuclear stain-DAPI; and

Dye 2, a lectin-WGA-FITC) were subsequently applied to the oral

cavity. Biopsies of clinically suspicious areas (including areas of

aberrant molecular probe staining) were obtained for histopatho-

logical diagnosis by a board certified oral pathologist. Sensitivity

and specificity metrics for the data were calculated by correlating

fluorescence results to histopathological diagnoses.

This

in vivo

clinical study was performed on 25 patients with a

variety of oral mucosal conditions. The results confirmed a sensi-

tivity of 100% in cancer, 80% in dysplasia with a 60% specificity.

This system is a noninvasive, low-cost and consistent method in

enhancing the early identification of malignant lesions and holds

the promise for earlier detection of oral cancer.

http://dx.doi.org/10.1016/j.ijom.2017.02.700

Healing mechanism and osteogenic capacity of bovine bone

mineral—human amniotic mesenchymal stem cell and

autogenous bone graft in critical size mandibular defect

D.B. Kamadjaja

∗

, Purwati, Ferdiansyah, F.A. Rantam,

C. Pramono

Universitas Airlangga, Surabaya, Indonesia

Background:

Maxillofacial bone engineering showed promising

result; however, its healing mechanisms and effectiveness had not

been fully understood.

Objectives:

The study compared the bone healing mechanism and

osteogenic capacity between bovine bone mineral (BBM) scaffold

loaded with human amniotic membrane stem cell (hAMSC) and

autogenous bone graft (ABG) in the reconstruction of critical size

mandibular defect.

Methods:

Critical size defects were made at mandible of 45

New Zealand White rabbits which were subsequently recon-

structed with BBM-hAMSC, BBM alone, and ABG, respectively.

At the end of first, second, and twelfth weeks, five rabbits from

each group were sacrificed for histology and immunohistochem-

istry staining. Expressions of vascular endothelial growth factor

(VEGF), bone morphogenetic protein-2 (BMP-2), Runt-related

transcription factor 2 (Runx2) and angiogenesis were analysed in

first and second week, while Runx2, osteocalcin, collagen-I fibres,

trabecular area and bone incorporation were analysed in twelfth

week.

Findings:

Expressions of VEGF, BMP-2, Runx2 and angiogene-

sis were higher in ABG compared with BBM-hAMSC group in the

first and second week group. In twelfth week expressions of Runx2

and osteocalcin as well as thickness of collagen-I fibres were sig-

nificantly higher in BBM-hAMSC compared to ABG group, while

there was no statistically difference in trabecular area and bone

incorporation between BBMhAMSC and ABG group.

Conclusion:

Early healing activities were higher in ABG than

in BBM-hAMSC, while osteogenic activities in the late stage of

healing were higher in BBM-hAMSC compared to ABG. In addi-

tion, the osteogenic capacity of BBM-hAMSC was comparable to

ABG in the reconstruction of critical size defect in the mandible.

http://dx.doi.org/10.1016/j.ijom.2017.02.701

Secreted ectodomain of sialic acid-binding

immunoglobulin-like lectin-9 and monocyte chemoattractant

protein-1 derived from dental pulp stem cells synergistically

regenerate transected rat peripheral nerves by altering

macrophage polarity

F. Kano

∗

, A. Yamamoto, K. Matsubara, H. Hibi

Nagoya University Graduate School of Medicine, Nagoya, Japan

Background:

We previously reported that the implantation of

a collagen graft soaked with serum-free conditioned medium

(CM) from the stem cells of human exfoliated deciduous teeth

(SHED-CM) into the nerve gap promotes neuronal regeneration,

however therapeutic mechanisms are elusive. In another study, we

identified a set of M2 macrophage inducers, monocyte chemoat-

tractant protein-1 (MCP-1) and the secreted ectodomain of sialic

acid-binding immunoglobulin (Ig)-like lectin-9 (sSiglec-9) in

SHED-CM, and showed that they promote functional recovery

after rat spinal cord injury.

Objective:

We examined the therapeutic effects of MCP-1 and

ED-Siglec-9 in the treatment of the peripheral facial nerve injury.

Methods:

The rat facial nerve was resected 5 mm. Next an atelo-

collagen sponge impregnated, MCP-1 and sSiglec-9 was placed

in the nerve gap. The neurological recovery of the transected FN

was assessed by examination of vibrissae movements (VMs), his-

tological analysis with electron microscope, and gene expression

analysis with real-time polymerase chain reaction. Human Schwan

cells (SCs) were cultured for 24 h with CM from MCP-1/sSiglec-

9-induced M2 macrophage (M2-CM). Effects of M2-CM for

proliferation, migration and differentiation of SCs were evaluated.

Results:

SHED-CM or MCP-1/sSiglec-9-treated rats exhibited

markedly improved VMs that were synchronised with that of the

contralateral uninjured side five weeks after injury. The FN of

both treatment groups displayed each many myelinated axons.

M2macrophages converts proinflammatory circumstances to anti-

inflammatory one, and promote to proliferation, migration and

differentiation of SCs.

Conclusion:

SHED-CM and MCP-1/sSiglec-9 may provide a

novel strategy to treat the FNI.

http://dx.doi.org/10.1016/j.ijom.2017.02.702